Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Mar 14, 2017 · 10-K · 73 days after period end · 0001564590-17-004158
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Net Income | -$6.22M | -$1.47M | $1.05M | $857.00K |
| EPS Diluted | -$0.18 | -$0.03 | $0.02 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 14, 2017 · 73 d after period end
